Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Abingdon Health PLC ( (GB:ABDX) ) has provided an announcement.
Abingdon Health has triggered the full earn-out payment for its 2024 acquisition of regulatory services firm IVDeology after the business achieved the maximum revenue target over a two-year period. The company will settle the £200,000 consideration by issuing 1,673,640 new ordinary shares to the vendors, which will be subject to a one-year lock-in followed by a 12-month orderly market period.
The new shares, which rank pari passu with existing stock, are expected to be admitted to trading on AIM on 26 May 2026, lifting Abingdon’s total share capital to 252,751,490 ordinary shares. The expanded equity base reflects the successful integration and performance of IVDeology, reinforcing Abingdon’s regulatory services offering and providing clarity for investors on voting rights and disclosure thresholds.
Spark’s Take on ABDX Stock
According to Spark, TipRanks’ AI Analyst, ABDX is a Neutral.
The score is held back primarily by weak financial quality—ongoing losses, declining gross margin, and negative operating cash flow—despite strong revenue growth. Technicals are supportive with the price above major moving averages and a positive MACD, but elevated RSI indicates potential near-term overheating. Valuation is constrained by negative earnings and the absence of a dividend yield.
To see Spark’s full report on ABDX stock, click here.
More about Abingdon Health PLC
Abingdon Health is a med-tech contract service provider specialising in the development, manufacture and regulatory support of rapid lateral flow diagnostic tests for an international customer base. The group offers CDMO services, regulatory consulting and analytical testing across sectors including infectious disease, clinical diagnostics, animal health and environmental testing, operating from facilities in the U.K. and the U.S.
Average Trading Volume: 403,767
Technical Sentiment Signal: Buy
Current Market Cap: £28.87M
For detailed information about ABDX stock, go to TipRanks’ Stock Analysis page.